Skip to main content

Published locations for Evolocumab safe, well-tolerated in HIV+ patients

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. Evolocumab safe, well-tolerated in HIV+ patients

User login

  • Reset your password
  • /content/evolocumab-safe-well-tolerated-hiv-patients
  • /familypracticenews/article/222034/lipid-disorders/evolocumab-safe-well-tolerated-hiv-patients
  • /idpractitioner/article/222034/lipid-disorders/evolocumab-safe-well-tolerated-hiv-patients
  • /internalmedicinenews/article/222034/lipid-disorders/evolocumab-safe-well-tolerated-hiv-patients
  • /clinicalendocrinologynews/article/222034/lipid-disorders/evolocumab-safe-well-tolerated-hiv-patients
  • /ecardiologynews/article/222034/lipid-disorders/evolocumab-safe-well-tolerated-hiv-patients
  • /cardiology/article/222034/lipid-disorders/evolocumab-safe-well-tolerated-hiv-patients
  • /infectiousdisease/article/222034/lipid-disorders/evolocumab-safe-well-tolerated-hiv-patients
  • /endocrinology/article/222034/lipid-disorders/evolocumab-safe-well-tolerated-hiv-patients
  • /internalmedicine/article/222034/lipid-disorders/evolocumab-safe-well-tolerated-hiv-patients
  • /familymedicine/article/222034/lipid-disorders/evolocumab-safe-well-tolerated-hiv-patients